Adam M. Klein
International Corporate and Securities Department
Adv. Klein is a partner and Deputy Department Head of the International Corporate and Securities Department. Adv. Klein specializes in Israeli and international corporate and finance transactions, including public offerings, mergers and acquisitions, tender offers, 'going private' transactions, spin-offs, PIPEs, and private equity and venture capital investments.
Adv. Klein advises many Israeli SEC-registered companies and dual-listed companies on their corporate governance requirements under Israeli law and under the rules of the SEC, NYSE, and NASDAQ. Adv. Klein also advises foreign companies on their acquisitions, investments and business activities in Israel. He possesses particular expertise in U.S. public offerings.
In recent years, Adv. Klein has advised on some of the largest and most complex merger and acquisition transactions and cross-border public offerings in Israel, in which he has represented multinational corporations in Israeli transactions, as well as Israeli corporations in overseas transactions.
Adv. Klein has been recognized as one of Israel's leading attorneys in the capital markets, corporate and M&A fields by Chambers & Partners and Best Lawyers.
Adv. Klein advised the Ethics Committee of the Israel Bar Association on rules of conduct for attorneys under the Sarbanes-Oxley Act; crafted the first Shareholder Rights Plan ('Poison Pill') in Israel, which enables public companies to defend themselves from hostile takeovers; and lectures to professional audiences on a variety of legal topics.
From 1992 to 1999, Adv. Klein was an associate in the Corporate and Financial Services Department of Willkie Farr & Gallagher, New York.
J.D., Columbia Law School, New York, 1991
Notes Editor, Columbia Journal of Transnational Law
B.A. (magna cum laude), English Literature, Yeshiva University, New York, 1987
Israel Bar Association, 2000
New York Bar Association, 1992